188 related articles for article (PubMed ID: 26752119)
1. Effect of escitalopram versus placebo on GRα messenger RNA expression in peripheral blood cells of healthy individuals with a family history of depression - a secondary outcome analysis from the randomized AGENDA trial.
Knorr U; Koefoed P; Gluud C; Wetterslev J; Winkel P; Gether U; Vinberg M; Kessing LV
Nord J Psychiatry; 2016; 70(4):297-302. PubMed ID: 26752119
[TBL] [Abstract][Full Text] [Related]
2. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial.
Knorr UB
Dan Med J; 2012 Apr; 59(4):B4426. PubMed ID: 22459724
[TBL] [Abstract][Full Text] [Related]
3. The effect of escitalopram versus placebo on perceived stress and salivary cortisol in healthy first-degree relatives of patients with depression-A randomised trial.
Knorr U; Vinberg M; Gether U; Winkel P; Gluud C; Wetterslev J; Kessing LV
Psychiatry Res; 2012 Dec; 200(2-3):354-60. PubMed ID: 22703642
[TBL] [Abstract][Full Text] [Related]
4. Escitalopram and neuroendocrine response in healthy first-degree relatives to depressed patients--a randomized placebo-controlled trial.
Knorr U; Vinberg M; Hansen A; Klose M; Feldt-Rasmussen U; Hilsted L; Hasselstrøm J; Gether U; Winkel P; Gluud C; Wetterslev J; Kessing LV
PLoS One; 2011; 6(6):e21224. PubMed ID: 21738622
[TBL] [Abstract][Full Text] [Related]
5. Reduced Glucocorticoid Receptor alpha Expression in Mood Disorder Patients and First-Degree Relatives.
Matsubara T; Funato H; Kobayashi A; Nobumoto M; Watanabe Y
Biol Psychiatry; 2006 Apr; 59(8):689-95. PubMed ID: 16458268
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.
Flandreau EI; Bourke CH; Ressler KJ; Vale WW; Nemeroff CB; Owens MJ
Psychoneuroendocrinology; 2013 Aug; 38(8):1349-61. PubMed ID: 23267723
[TBL] [Abstract][Full Text] [Related]
7. Molecular changes associated with escitalopram response in a stress-based model of depression.
Benatti C; Alboni S; Blom JMC; Mendlewicz J; Tascedda F; Brunello N
Psychoneuroendocrinology; 2018 Jan; 87():74-82. PubMed ID: 29049934
[TBL] [Abstract][Full Text] [Related]
8. Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats.
Buhl ES; Jensen TK; Jessen N; Elfving B; Buhl CS; Kristiansen SB; Pold R; Solskov L; Schmitz O; Wegener G; Lund S; Petersen KF
Am J Physiol Endocrinol Metab; 2010 May; 298(5):E920-9. PubMed ID: 20103738
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
[TBL] [Abstract][Full Text] [Related]
10. Blood mRNA expression levels of glucocorticoid receptors and FKBP5 are associated with depressive disorder and altered HPA axis.
Hori H; Yoshida F; Ishida I; Matsuo J; Ogawa S; Hattori K; Kim Y; Kunugi H
J Affect Disord; 2024 Mar; 349():244-253. PubMed ID: 38199409
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial.
Knorr U; Vinberg M; Mortensen EL; Winkel P; Gluud C; Wetterslev J; Gether U; Kessing LV
PLoS One; 2012; 7(2):e31980. PubMed ID: 22393376
[TBL] [Abstract][Full Text] [Related]
12. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
Waugh J; Goa KL
CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
[TBL] [Abstract][Full Text] [Related]
13. Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.
Nothdurfter C; Schmotz C; Sarubin N; Baghai TC; Laenger A; Lieb M; Bondy B; Rupprecht R; Schüle C
J Psychiatr Res; 2014 May; 52():15-20. PubMed ID: 24513501
[TBL] [Abstract][Full Text] [Related]
14. Escitalopram alleviates stress-induced Alzheimer's disease-like tau pathologies and cognitive deficits by reducing hypothalamic-pituitary-adrenal axis reactivity and insulin/GSK-3β signal pathway activity.
Wu C; Gong WG; Wang YJ; Sun JJ; Zhou H; Zhang ZJ; Ren QG
Neurobiol Aging; 2018 Jul; 67():137-147. PubMed ID: 29656013
[TBL] [Abstract][Full Text] [Related]
15. No effect of escitalopram versus placebo on brain-derived neurotrophic factor in healthy individuals: a randomised trial.
Knorr U; Koefoed P; Soendergaard MH; Vinberg M; Gether U; Gluud C; Wetterslev J; Winkel P; Kessing LV
Acta Neuropsychiatr; 2016 Apr; 28(2):101-9. PubMed ID: 26573431
[TBL] [Abstract][Full Text] [Related]
16. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.
Kornstein SG; Bose A; Li D; Saikali KG; Gandhi C
J Clin Psychiatry; 2006 Nov; 67(11):1767-75. PubMed ID: 17196058
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of antidepressants on dexamethasone-induced nuclear translocation and expression of glucocorticoid receptor.
Funato H; Kobayashi A; Watanabe Y
Brain Res; 2006 Oct; 1117(1):125-34. PubMed ID: 16956592
[TBL] [Abstract][Full Text] [Related]
18. Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram.
Lenze EJ; Mantella RC; Shi P; Goate AM; Nowotny P; Butters MA; Andreescu C; Thompson PA; Rollman BL
Am J Geriatr Psychiatry; 2011 May; 19(5):482-90. PubMed ID: 20808146
[TBL] [Abstract][Full Text] [Related]
19. The effects of six-day SSRI administration on diurnal cortisol secretion in healthy volunteers.
Ronaldson A; Carvalho LA; Kostich K; Lazzarino AI; Urbanova L; Steptoe A
Psychopharmacology (Berl); 2018 Dec; 235(12):3415-3422. PubMed ID: 30283981
[TBL] [Abstract][Full Text] [Related]
20. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
